Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
80,689
-
Share change
-
-42,748
-
Total reported value
-
$2,870,914
-
Price per share
-
$35.58
-
Number of holders
-
2
-
Value change
-
-$1,386,175
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q4 2023
As of 31 Dec 2023,
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,689 shares.
The largest 10 holders included
BlackRock Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, FMR LLC, STATE STREET CORP, VANGUARD GROUP INC, Point72 Asset Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, and T. Rowe Price Investment Management, Inc..
This page lists
180
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.